The Therapeutic Goods Administration (TGA) has approved Pfizer Australia and BioNTech SE’s XBB.1.5-adapted monovalent COVID-19 vaccine (COMIRNATY® Omicron XBB.1.5) for individuals aged 5 and over. The decision follows evidence that this vaccine can better protect against symptomatic and severe COVID-19. The vaccine is free and available at pharmacies and general practices across Australia.
Chinese Hackers Target European Diplomats with Malware
MirrorFace, a threat actor tied to Chinese cyberespionage, has expanded its activity outside East Asia, targeting a European organization with updated hacking tools. Researchers from
